The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect ... Harris Administration and HHS,” HHS Secretary Xavier Becerra said in a statement Friday.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

The award will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza ... HHS Secretary Xavier Becerra said in a statement: “Avian flu variants ...

The award will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza ... stay safe,” HHS Secretary Xavier Becerra said in a statement.

HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine ...

The award will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza ... to stay safe," HHS Secretary Xavier Becerra said in a statement.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans. This is in ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...